Department of Pharmaceutical Technology, Institute of Pharmacy, Leopold-Franzenz-University of Innsbruck, Innrain 80/82, 6020 Innsbruck, Austria.
Carbohydr Polym. 2012 Oct 1;90(2):765-72. doi: 10.1016/j.carbpol.2012.05.028. Epub 2012 May 14.
Purpose of the present study was the generation and evaluation of novel thiolated chitosans, so-named S-protected thiolated chitosans as mucosal drug delivery systems. Stability of all conjugates concerning swelling and disintegration behavior as well as drug release was examined. Mucoadhesive properties were evaluated in vitro on intestinal mucosa. Different thiolated chitosans were generated displaying increasing amounts of attached free thiol groups on the polymer, whereby more than 50% of these thiol groups were linked with 6-mercaptonicotinamide. Based on the implementation of this hydrophobic residue, the swelling behavior was 2-fold decreased, whereas stability was essentially improved. Their mucoadhesive properties were 2- and 14-fold increased compared to corresponding thiolated and unmodified chitosans, respectively. Release studies out of matrix tablets comprising the novel conjugates revealed a controlled release of a model peptide. Accordingly, S-protected thiomers represent a promising type of mucoadhesive polymers for the development of various mucosal drug delivery systems.
本研究的目的是制备新型巯基化壳聚糖,并将其作为黏膜给药系统进行评估。研究考察了所有缀合物在膨胀和崩解行为以及药物释放方面的稳定性。在体外,通过评估对肠黏膜的黏附性能来研究其黏附性能。不同的巯基化壳聚糖被制备出来,其聚合物上附着的游离巯基数量逐渐增加,其中超过 50%的巯基与 6-巯基烟酰胺相连。基于这种疏水性残基的引入,其溶胀行为降低了约 2 倍,而稳定性则得到了显著改善。与相应的巯基化和未修饰壳聚糖相比,其黏附性能分别提高了 2 倍和 14 倍。包含新型缀合物的基质片剂的释放研究表明,模型肽呈控制释放。因此,S-保护的硫醚代表了一类有前途的黏附性聚合物,可用于开发各种黏膜给药系统。